NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
Kefid · The incidence of NY‐ESO‐1 is also interesting to compare between groups in different countries. For example, non‐small cell lung cancer (NSCLC) appears to have a 20–25% expression rate of NY‐ESO‐1 in most US studies, while it is only rarely found in Japan ().Squamous cell carcinoma of the lung is more common in Japan while adenocarcima is …
Get a Quote